Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin

NCT04852510 is registered in ClinicalTrials.gov with Saudi German Hospital - Madinah as lead sponsor.

NCT NCT04852510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin
Lead sponsor
Saudi German Hospital - Madinah
Phase
Phase 2/3
Overall status
Completed
Start date
February 1, 2019
Completion date
August 31, 2020
Enrollment
253 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovary syndrome (pcos)